New York, USA, 2023-Jul-10 — /EPR Network/ — Considering a recently featured article by NIH introducing the therapeutic effects of NSC-derived exosomes in cerebral ischemia, Creative [read full press release…]
New York, USA, 2022-Nov-01 — /EPR Network/ — Creative Biolabs provides advanced analytics and exosome engineering solutions to drive exosomal targeting delivery studies. Exosomes, a [read full press release…]
New York, USA, 2022-Oct-04 — /EPR Network/ — To extend the upstream production and downstream applications of exosomes, Creative Biolabs collects new strategies and technologies to [read full press release…]
New York, USA, 2022-Aug-17 — /EPR Network/ — Creative Biolabs is looking to help exosome researchers and streamline their projects, with the public launch of [read full press release…]
New York, USA, 2022-Jul-13 — /EPR Network/ — Updated services from Creative Biolabs target exosome contents, including proteins, lipids, and mRNA in terms of their application [read full press release…]
New York, USA, 2022-Jun-14 — /EPR Network/ — Creative Biolabs expands exosome engineering services for wider applications, especially for loading cargo into exosomes and targeting delivery. [read full press release…]
New York, USA, 2022-Feb-21 — /EPR Network/ — To better aid SARS-CoV-2 drug discovery, Creative Biolabs updates its exosome services for displaying ACE2 variants on [read full press release…]
New York, USA, 2022-Jan-10 — /EPR Network/ — With the identified role of lipids in exosome biology and intercellular communication, Creative Biolabs highlights the importance [read full press release…]
Shirley, NY, 2021-Dec-08 — /EPR Network/ — Since exosomes and their molecular contents keep attracting researchers’ interest in exploring exosomes as biomarkers and diagnostic tools, Creative Biolabs offers further [read full press release…]
